ストックスクリーナーアプリを入手
2.07
0.00%
0.00
前日終値:
$2.07
開ける：
$2.07
24時間の取引高:
33,024
Relative Volume:
0.72
時価総額：
$46.92M
収益：
$35.16M
当期純損益:
$-11.44M
株価収益率:
-3.4726
EPS:
-0.5961
ネットキャッシュフロー:
$-15.44M
1週間 パフォーマンス:
-19.14%
1か月 パフォーマンス:
-25.81%
6か月 パフォーマンス:
-56.60%
1年 パフォーマンス:
-77.54%
1日の値動き範囲:
$2.02
$2.155
1週間の範囲:
$2.01
$2.62
52週間の値動き範囲:
$1.82
$12.80
Bioharvest Sciences Inc Stock (BHST) Company Profile
Compare BHST vs JBS, KHC, GIS, MKC, HRL
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
2.07 | 48.74M | 35.16M | -11.44M | -15.44M | -0.5961 |
JBS
Jbs Nv
|
13.65 | 43.16B | 88.25B | 1.91B | -681.64M | 1.6761 |
KHC
Kraft Heinz Co
|
25.51 | 29.09B | 24.99B | -5.76B | 3.95B | -4.863 |
GIS
General Mills Inc
|
39.20 | 20.38B | 18.42B | -85.30M | 1.63B | -0.1894 |
MKC
Mccormick Co Inc
|
54.67 | 14.24B | 7.39B | 1.63B | 1.02B | 6.0085 |
HRL
Hormel Foods Corp
|
24.54 | 13.42B | 12.22B | 466.64M | 692.94M | 0.8477 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-19 | 開始されました | Roth Capital | Buy |
| 2025-05-05 | 開始されました | Craig Hallum | Buy |
| 2024-12-18 | 開始されました | Maxim Group | Buy |
Bioharvest Sciences Inc (BHST) 最新ニュース
BioHarvest Sciences Inc. (NASDAQ:BHST) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
BHST Maintains Rating by Maxim Group -- Price Target Lowered to $5.00 - GuruFocus
BioHarvest Sciences Inc. Common Stock (NASDAQ: BHST) Stock Price, News & Analysis - Kalkine
BHST Maintained by Roth Capital -- Price Target Lowered to $8.00 - GuruFocus
BioHarvest at canaccord growth conference: scaling plant-cell platform By Investing.com - Investing.com Canada
BioHarvest Sciences: Patented cell culture platform secures $20–30M fragrance deal, targets $40M revenue and profitability - TradingView
BioHarvest at canaccord growth conference: scaling plant-cell platform - Investing.com
BioHarvest Sciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
BioHarvest Sciences (BHST) Q2 2026 Earnings Call Transcript - AOL.com
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlights: Strategic Pivot to ... By GuruFocus - Investing.com Canada
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlight - GuruFocus
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlights: Strategic Pivot to ... - Yahoo Finance
What Could BioHarvest Sciences (NASDAQ:BHST) Quarterly Update Show? - Kalkine Media
BioHarvest Sciences Inc. Common Stock Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: BioHarvest Sciences posts smaller Q2 2026 loss By Investing.com - Investing.com Canada
BioHarvest Sciences cuts FY26 revenue guidance for CDMO and VINIA D2C - scanx.trade
Transcript : BioHarvest Sciences Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com
BioHarvest Sciences Q2 Earnings Call Highlights - MarketBeat
BioHarvest Sciences: Secured first major CDMO contract and reaffirmed 2027 EBITDA breakeven despite revised 2026 guidance - TradingView
BioHarvest Sciences: Secured a transformative fragrance CDMO contract, driving revenue growth and 2027 EBITDA breakeven - TradingView
Earnings call transcript: BioHarvest Sciences posts smaller Q2 2026 loss - Investing.com
BioHarvest Sciences shares surge 11% after major fragrance manufacturing deal - Yahoo Finance
BioHarvest Sciences shares surge 11% on major fragrance deal By Investing.com - Investing.com Canada
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
BioHarvest secures fragrance manufacturing deal worth $20-30M By Investing.com - Investing.com Australia
BioHarvest secures first CDMO manufacturing dea... - Pluang
BioHarvest Sciences shares surge 11% on major fragrance deal - Investing.com
BioHarvest Sciences: Q2 revenue up 3.8% to $8.8M; first CDMO deal signed; full-year guidance revised downward - TradingView
BioHarvest secures fragrance manufacturing deal worth $20-30M - Investing.com
BioHarvest Sciences Announces Q2 2026 Financial Results and Secures Inaugural CDMO Fragrance Manufacturing Contract for 20-Ton Production - Kalkine Media
BioHarvest Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BioHarvest Sciences Lands Exclusive 20-Tonne Rare Fragrance Production Deal Worth $20–$30 Million - Kalkine Media
BioHarvest posts higher Q2 revenue, secures manufacturing deal for premium fragrance compound - Proactive financial news
Bioharvest Sciences Inc (BHST) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market - 富途牛牛
BioHarvest Sciences (BHST) Holds Steady at $2.26, Trapped Between $2.15 Support and $2.37 ResistanceRetail Volume - dars.gov.et
Enterprise value to EBIT forward of BioHarvest Sciences, Inc. – FWB:8MV0 - TradingView
Price to sales forward of BioHarvest Sciences, Inc. – MUN:8MV0 - tradingview.com
BioHarvest Sciences CEO to Present at Canaccord Genuity 46th Annual Growth Conference in Boston - kalkine.ca
BioHarvest Sciences CEO to present at Canaccord Genuity conference - Proactive financial news
BioHarvest Sciences to Unveil Q2 2026 Financial Results on August 11, 2026 - Kalkine Media
BioHarvest CEO to discuss first 100 days and 2026 growth plan - Stock Titan
BioHarvest to report Q2 2026 earnings and host a conference call on August 11 - Pluang
Bioharvest Sciences Inc (BHST) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bioharvest Sciences Inc (BHST) Balance Sheet - TradingKey
Bioharvest Sciences Inc (BHST) Cash Flow - TradingKey
Bioharvest Sciences Inc (BHST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BioHarvest Sciences, Inc. Revenue Breakdown – LSX:A40C6G - TradingView
BioHarvest Sciences Inc. Revenue Breakdown – NASDAQ:BHST - TradingView
Bioharvest Sciences Inc (BHST) Income Statement - tradingkey.com
Bioharvest Sciences Inc (BHST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bioharvest Sciences Inc (BHST) 財務データ
収益
当期純利益
現金流量
EPS
1.49%
2.54%
大文字化:
|
ボリューム (24 時間):